Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine.
Drug testing and analysis · Abstract available
All research
COMPOUND RESEARCH
Tesofensine
Follow the papers. Understand the context.
2 papers · 4 trial recordsChecked 18 Sept 2026
This is a non-peptide compound included in the site's existing reference collection.
Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons.
PloS one · Abstract available
Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)
NCT03149445 · completed · Results posted
48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)
NCT03845075 · completed · Results posted
Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
NCT05147415 · withdrawn · No results posted in this snapshot
Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
NCT05198362 · withdrawn · No results posted in this snapshot
Publications match compound names in their titles. Trial matches use intervention names. An association with a compound is not a finding about its effectiveness. How we select records.